Showing results (31-40 of 280) with videos related to
Sort By:
Pageof 28
Cancer Research Communications|December 18, 2023
Analysis of Changes in Plasma Cytokine Levels in Response to IL12 Therapy in Three Clinical TrialsEmily Schwarz, Brooke Benner, Lianbo Yu, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 12, 2012
Monoclonal antibody therapy of pancreatic cancer with cetuximab: potential for immune modulationEric Luedke, Alena Cristina Jaime-Ramirez, Neela Bhave, et al.Clinical, Cosmetic and Investigational Dermatology|September 6, 2022
Ulcerated Cutaneous Melanoma: A Review of the Clinical, Histologic, and Molecular Features Associated with a Clinically Aggressive Histologic PhenotypeZoe Barricklow, Mallory J DiVincenzo, Colin D Angell, et al.Cancer Immunology, Immunotherapy : CII|July 9, 2017
Circulating myeloid-derived suppressor cells increase in patients undergoing neo-adjuvant chemotherapy for breast cancerRobert Wesolowski, Megan C Duggan, Andrew Stiff, et al.The Journal of Biological Chemistry|December 1, 2010
E2f1-3 are critical for myeloid developmentPrashant Trikha, Nidhi Sharma, Rene Opavsky, et al.Cancer Immunology Research|July 21, 2017
MICA-Expressing Monocytes Enhance Natural Killer Cell Fc Receptor-Mediated Antitumor FunctionsAmanda R Campbell, Megan C Duggan, Lorena P Suarez-Kelly, et al.Psychosomatic Medicine|July 23, 2009
A psychological intervention reduces inflammatory markers by alleviating depressive symptoms: secondary analysis of a randomized controlled trialLisa M Thornton, Barbara L Andersen, Tammy A Schuler, et al.Brain, Behavior, and Immunity|August 16, 2006
Individual trajectories in stress covary with immunity during recovery from cancer diagnosis and treatmentsLisa M Thornton, Barbara L Andersen, Timothy R Crespin, et al.Breast Cancer Research and Treatment|July 6, 2013
Myeloid-derived suppressor cells in breast cancerJoseph Markowitz, Robert Wesolowski, Tracey Papenfuss, et al.Oncotarget|December 2, 2016
Targeting tissue factor as a novel therapeutic oncotarget for eradication of cancer stem cells isolated from tumor cell lines, tumor xenografts and patients of breast, lung and ovarian cancerZhiwei Hu, Jie Xu, Jijun Cheng, et al.Pageof 28